Bayesian Capital Management’s Travelers Companies TRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,931
Closed -$1.39M 1000
2024
Q3
$1.39M Buy
+5,931
New +$1.31M 0.16% 187
2024
Q2
Sell
-4,168
Closed -$959K 1101
2024
Q1
$959K Buy
+4,168
New +$890K 0.09% 293
2023
Q4
Sell
-7,153
Closed -$1.17M 1033
2023
Q3
$1.17M Sell
7,153
-5,500
-43% -$919K 0.13% 187
2023
Q2
$2.2M Buy
+12,653
New +$2.23M 0.24% 109
2022
Q3
Sell
-1,936
Closed -$327K 1018
2022
Q2
$327K Buy
1,936
+758
+64% +$132K 0.06% 451
2022
Q1
$215K Buy
+1,178
New +$202K 0.03% 631
2021
Q4
Sell
-1,998
Closed -$304K 516
2021
Q3
$304K Sell
1,998
-7,768
-80% -$1.2M 0.09% 264
2021
Q2
$1.46M Buy
9,766
+8,026
+461% +$1.25M 0.38% 71
2021
Q1
$262K Buy
+1,740
New +$256K 0.06% 385
2019
Q3
Sell
-7,174
Closed -$1.07M 687
2019
Q2
$1.07M Buy
+7,174
New +$1.03M 0.22% 131
2018
Q2
Sell
-8,700
Closed -$1.21M 735
2018
Q1
$1.21M Buy
+8,700
New +$1.22M 0.31% 89
2016
Q1
Sell
-2,767
Closed -$312K 441
2015
Q4
$312K Buy
+2,767
New +$307K 0.45% 90

Other funds holding TRV

Bayesian Capital Management's TRV Position: Q4 2024 in Review

Bayesian Capital Management sold out of Travelers Companies (TRV) in Q4 2024, closing a stake of 5,931 shares — an estimated $1.39M sold.

Bayesian Capital Management first reported a position in TRV in Q4 2015 and held it in 12 quarters. The position peaked at $2.2M in Q2 2023. 1,577 funds tracked by Wall St. Rank hold TRV as of Q4 2024.

  • Bayesian Capital Management reported no remaining Travelers Companies position as of Q4 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 5,931 Travelers Companies shares in Q4 2024, an estimated $1.39M.
  • Bayesian Capital Management first reported a position in Travelers Companies in Q4 2015 and held it in 12 quarters.
  • Bayesian Capital Management's Travelers Companies position peaked at $2.2M in Q2 2023.
  • 1,577 funds tracked by Wall St. Rank held Travelers Companies as of Q4 2024.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.